Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Hutton Scott, Chairman & CEO. Insider active across 1 company, notably BIODESIX INC. Cumulatively, 23 reports have been logged. Breakdown: 1 buy · 1 sell. Total volume traded: €24k. History available since 17 November 2021. The latest transaction was disclosed on 16 January 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
3,000 shares@ US$6.45830.032% mcap50.0% of flowCommon StockSEC:0001567619-21-020776:0
Canonical exit: 15 Feb 2022 (T+90)
23 of 23 declarations
About Hutton Scott
Scott Hutton is President and CEO of Biodesix Inc. He leads the company with a focus on innovation and improving patient care. His leadership is essential for the mission and objectives of Biodesix.